Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Division of Cardiology, Medical University of South Carolina, Charleston, South Carolina, USA.
J Cardiovasc Electrophysiol. 2024 Sep;35(9):1806-1816. doi: 10.1111/jce.16356. Epub 2024 Jul 12.
Scar substrate in nonischemic cardiomyopathy (NICM) patients is often difficult to identify. Advances in cardiac imaging, especially using late iodine-enhanced computed tomography (LIE-CT), allow better characterization of scars giving rise to ventricular tachycardia (VT). Currently, there are limited data on clinical correlates of CT-derived scar substrates in NICM. We sought assess the relationship between scar location on LIE-CT and outcomes after radiofrequency catheter ablation (RFCA) in NICM patients with VT.
From 2020 to 2022, consecutive patients with NICM undergoing VT RFCA with integration of cardiac CT scar modeling (inHeart, Pessac, France) were included at two US tertiary care centers. The CT protocol included both arterial-enhanced imaging for anatomical modeling and LIE-CT for scar assessment. The distribution of substrate on CT was analyzed in relation to patient outcomes, with primary endpoints being VT recurrence and the need for repeat ablation procedure.
Sixty patients were included (age 64 ± 12 years, 90% men). Over a median follow-up of 120 days (interquartile range [IQR]: 41-365), repeat ablation procedures were required in 32 (53%). VT recurrence occurred in 46 (77%), with a median time to recurrence of 40 days (IQR: 8-65). CT-derived total scar volume positively correlated with intrinsic QRS duration (r = .34, p = 0.008). Septal scar was found on CT in 34 (57%), and lateral scar in 40 (7%). On univariate logistic regression, septal scar was associated with increased odds of repeat ablation (odds ratio [OR]: 2.9 [1.0-8.4]; p = 0.046), while lateral scar was not (OR: 0.9 [0.3-2.7]; p = 0.855). Septal scar better predicted VT recurrence when compared to lateral scar, but neither were statistically significant (septal scar OR: 3.0 [0.9-10.7]; p = 0.078; lateral scar OR: 1.7 [0.5-5.9]; p = 0.391).
In this tertiary care referral population, patients with NICM undergoing VT catheter ablation with septal LIE-CT have nearly threefold increased risk of need for repeat ablation.
非缺血性心肌病(NICM)患者的瘢痕基质通常难以识别。心脏成像技术的进步,特别是使用晚期碘增强计算机断层扫描(LIE-CT),可以更好地描述导致室性心动过速(VT)的瘢痕。目前,关于 NICM 中 CT 衍生瘢痕基质的临床相关性数据有限。我们旨在评估 LIE-CT 上瘢痕的位置与 NICM 合并 VT 患者射频导管消融(RFCA)后的结局之间的关系。
2020 年至 2022 年,在美国两家三级护理中心连续纳入接受 VT RFCA 并整合心脏 CT 瘢痕建模(inHeart,法国佩萨克)的 NICM 患者。CT 方案包括用于解剖建模的动脉增强成像和 LIE-CT 用于评估瘢痕。根据患者结局分析基质在 CT 上的分布,主要终点是 VT 复发和需要重复消融程序。
共纳入 60 例患者(年龄 64±12 岁,90%为男性)。在中位数为 120 天的随访期(四分位距[IQR]:41-365)中,32 例(53%)需要重复消融程序。46 例(77%)发生 VT 复发,复发中位时间为 40 天(IQR:8-65)。CT 衍生的总瘢痕体积与固有 QRS 持续时间呈正相关(r=0.34,p=0.008)。34 例(57%)在 CT 上发现间隔瘢痕,40 例(70%)发现外侧瘢痕。在单变量逻辑回归中,间隔瘢痕与重复消融的几率增加相关(比值比[OR]:2.9[1.0-8.4];p=0.046),而外侧瘢痕则没有(OR:0.9[0.3-2.7];p=0.855)。与外侧瘢痕相比,间隔瘢痕更能预测 VT 复发,但均无统计学意义(间隔瘢痕 OR:3.0[0.9-10.7];p=0.078;外侧瘢痕 OR:1.7[0.5-5.9];p=0.391)。
在这个三级护理转诊人群中,接受 VT 导管消融的 NICM 患者的 LIE-CT 中存在间隔瘢痕,需要重复消融的风险几乎增加了三倍。